Resources

Dental exams may be earlier predictor of disease than even blood tests.

Researchers compare fasting BG, HbA1c and 2-hour plasma glucose test.

Trials find intensive control reduced cardiovascular events in high-risk, diagnosed patients.

Excessive weight gain due to intensive therapy can lead to increased cardiovascular risk factors.

Post-hoc analysis of the breakthrough EMPA-REG Outcome trial demonstrated reduction in composite cardiovascular outcomes that can be seen with empagliflozin therapy.

Study shows that good periodontal health is necessary to achieve a favorable glycemic status.

Would you vote for Medicare for All? Follow the link to share your opinion.

Mrs. O’Doole is a 34 year-old of Irish descent. She works as a florist and is married with three children. She arrives at your clinic for her annual wellness exam. Her blood pressure is 130/84 mmHg, pulse 65, BMI 24 kg/m2 and her physical exam is notable for acne and mild hirsutism. Her only current medication is oral birth control pills. She recalls starting OCP, 15 years prior, due to irregular menses. Based upon her medical history and physical, you believe it would be prudent to screen Mrs. O’Doole for type 2 diabetes. The lab returns a fasting plasma glucose (FPG) of 112 mg/dL. You share these results with your patient and inform her that while only mildly elevated, she has impaired fasting glucose. You recommend that she see a diabetes educator to help her modify her diet and exercise to lose some weight. At a follow-up appointment 6 months later, Mrs. O’Doole tells you despite good intentions, she has not been able to adhere to any meaningful lifestyle changes. In fact, she has gained 5 pounds. At this time, her repeat fasting plasma glucose shows FPG 138 mg/dL. After discussing management options with her, you decide the best management would be: A. lifestyle modifications only B. metformin only C. metformin + continue with lifestyle modifications D. repaglinide only Follow the link for the answer.

Last week I was teaching a patient how to self inject an injectable medication. As I was going through the steps, I told her twice of the importance of removing not only the outer cover of the needle, but also the needle shield. She gave me one of those looks like, "Why did you tell me this twice?" Then she said, "I know!"

In part 2 of this Exclusive Interview, Dr. Swapnil N. Rajpathak talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the ultimate savings in the use of DPP4s — reduced risk of hypoglycemia.